Immunogenicity and safety of an Omicron XBB.1.16 adapted vaccine for COVID-19: Interim results from a randomized, controlled, non-inferiority clinical trial María Jesús López Fernandez, Silvia Narejos,Antoni Castro, José María Echave-Sustaeta,María José Forner,Eunate Arana-Arri, Josep Molto, Laia Bernad,Raúl Pérez-Caballero, Julia G Prado,Dàlia Raïch-Regué, Rytis Boreika,Nuria Izquierdo-Useros,Julià Blanco,Joan Puig-Barberà, Silvina Natalini Martínezcrossref(2024)引用 0|浏览14暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要